KDL Biotech share price history, delisted: KOPDRUGS

Last announcements

The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements

May 2018
- 18 May · Delisting
  Members of the Exchange are hereby notified that in terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Rule 21(2) b of Securities Contract (Regulations) Rules, 1957 , it has been decided to delist (withdraw the admission to dealings in) equity shares of the KDL Biotech Limited w.e.f. May 30, 2018 as per Chapter V of SEBI (Delisting of Equity Shares) Regulations, 2009. (opens in a new tab)
Jan 2018
- 24 Jan · Public Notice - Compulsory Delisting
  Members of the Exchange are hereby informed that the Exchange on January 18, 2018 has issued public notice in the newspaper for proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements). (opens in a new tab)
Feb 2015
- 18 Feb · Results
  Standalone financial results for the period ended 31-Dec-2014. (opens in a new tab)
- 13 Feb · Results
  Standalone financial results for the period ended 31-Dec-2013. (opens in a new tab)
- 12 Feb · Results
  Standalone Financial Results for the period ended June 30, 2013 to December 31, 2014. (opens in a new tab)
- 3 Feb · Board meeting
  Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held February 10, 2015: (1) To transact the following business: 1. To consider and approve Un-audited Financial Results for the quarters ended June 30, 2013, September 30, 2013, December 31, 2013, March 31, 2014, June 30, 2014, September 30, 2014 & December 31, 2014. 2. To consider and approve Annual Accounts for the financial year ended March 31, 2013. 3. To consider fixing the date of convening the Annual General Meeting of the Members of the Company. The Company has now informed the Exchange that the due to unavailable reason the Board Meeting of the company which was scheduled to be held on February 10, 2015 has been rescheduled on February 12, 2015.
  Not held on this date

Daily closes since Jan 2007, BSE closes Jan 2007 to Jul 2010, in Dec 2010, in Feb 2011, in Mar 2011, in Jun 2011, in Aug 2011, in Sep 2011, in Sep 2011, in Sep 2011, in Oct 2011, in Oct 2011, in Nov 2011, in Nov 2011, in Nov 2011, in Dec 2011, in Dec 2011, in Dec 2011, in Dec 2011, in Dec 2011, in Jan 2012, in Jan 2012, Jan 2012 to Feb 2012, in Feb 2012, in Feb 2012, in Feb 2012, in Mar 2012, in Mar 2012, in Mar 2012, in Mar 2012, in Mar 2012, in Apr 2012, in Apr 2012, in May 2012, in May 2012, in May 2012, in Jun 2012, in Jun 2012, in Jun 2012, in Jun 2012, in Jul 2012, in Jul 2012, in Jul 2012, in Jul 2012, Jul 2012 to Aug 2012, in Aug 2012, in Aug 2012, in Aug 2012, in Aug 2012, in Aug 2012, in Sep 2012, in Sep 2012, in Oct 2012, in Oct 2012, in Nov 2012, in Nov 2012, in Dec 2012, in Jan 2013, in Mar 2013, in Mar 2013, in Mar 2013, in Apr 2013, in Apr 2013, Apr 2013 to May 2013, May 2013 to Aug 2013, Aug 2013 to Nov 2013, in Nov 2013, in Nov 2013, Nov 2013 to Dec 2013 and Dec 2013 to Mar 2015, adjusted for splits and bonuses

Daily close, ₹ per share

Results

Standalone; ₹ crore, the charts by years to September, then March, the table by quarter. No standalone results on record for the year to Mar 2010.Quarterly results

Quarter to Dec 2014, against the quarter before

Revenue: –
Net profit: −₹3.33 CrQuarter to Sep 2014: −₹3.23 Cr

Revenue by year

Peak revenue ₹41 Cr, year to Sep 2008

Net profit by year, a loss in red

Net profit
Loss

A loss in 4 of the 4 years with results on record

The company moved its year end from September to March: its last year to September on record ended in Sep 2008, its first year to March in Mar 2011.

₹ crore	Mar 2013	Jun 2013	Sep 2013	Dec 2013	Mar 2014	Jun 2014	Sep 2014	Dec 2014
Revenue	5.13	0.99	–	–	–	–	–	–
Net profit	−3.61	−4.60	−4.11	−3.81	−4.43	−3.21	−3.23	−3.33
Net margin	−70.3%	−464.7%	–	–	–	–	–	–

Standalone. The last eight quarters. The latest is shaded.

Where the return came from

Yearly rates to Mar 2013, per-share figures restated for splits and bonuses.

Over	Return a year	Earnings growth	Change in P/E	Dividend yield
1 year	−52.5%	–	–	0.0%
3 years	−46.5%	–	–	0.0%
5 years	−30.5%	–	–	0.0%

Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.

KDL Biotech share price by year

Each calendar year to 2015.

Year	Close at year end	Change	Highest close	Lowest close
2015BSE close	2.14	+32.1%	2.25	1.70

₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2015 close is its last trade, on 16 Mar 2015.

Recent sessions

The last 10 trading days to 16 Mar 2015, as traded on BSE.

Date	Open	High	Low	Close	Average price	Volume
16 Mar 2015	2.14	2.14	2.14	2.14	2.14	4,811
9 Mar 2015	2.25	2.25	2.25	2.25	2.25	576
2 Mar 2015	2.15	2.15	2.15	2.15	2.15	1
23 Feb 2015	2.05	2.05	2.05	2.05	2.05	100
16 Feb 2015	1.90	1.98	1.90	1.98	1.93	800
9 Feb 2015	1.71	1.89	1.71	1.89	1.71	1,701
2 Feb 2015	1.77	1.80	1.77	1.80	1.78	150
19 Jan 2015	1.86	1.86	1.86	1.86	1.86	400
12 Jan 2015	1.78	1.78	1.78	1.78	1.78	770
5 Jan 2015	1.70	1.70	1.70	1.70	1.70	155

Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.

Ex-date	Event	Price factor	What happened
12 Nov 2013	Price move	–	Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.
12 Aug 2013	Price move	–	Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for.

Each event is noted and not adjusted for.

Company details

Legal name: KDL Biotech Ltd.
BSE code: 532291
ISIN: INE746A01010
Face value: ₹10
Former symbols: KOPDRUGS
Website: www.kdlbiotech.com (opens in a new tab)
CIN: L24230MH1986PLC040603; Corporate identity number, the registrar of companies' code for it